Wilmington, DE, United States of America

Gerard M McGeehan

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerard M McGeehan. Retrieved from https://idiyas.com/inventor/gerard-m-mcgeehan-1xi6p58g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gerard M McGeehan: A Pioneer in Therapeutic Uses

Introduction: Gerard M McGeehan, an accomplished inventor based in Wilmington, DE, has made significant contributions to the field of pharmaceuticals. With a focus on therapeutic applications, his work revolves around innovative compounds that target crucial biological receptors.

Latest Patents: McGeehan holds a patent for "Therapeutic uses of di-aryl acid derivatives." This patent delineates the use of diaryl acid derivatives and their variants, highlighting their effectiveness as PPAR (Peroxisome proliferator-activated receptor) ligand receptor binders. These compounds serve a dual purpose as either agonists or antagonists for the PPAR receptor, showcasing their potential in various therapeutic contexts.

Career Highlights: McGeehan is affiliated with Sanofi-a Ventis Deutschland GmbH, where he continues to develop and refine pharmaceutical innovations. His expertise and inventive spirit contribute to the company's commitment to advancing healthcare solutions.

Collaborations: Throughout his career, McGeehan has collaborated with notable colleagues, including Zaid Jayyosi and Michael F Kelley. These collaborations foster a productive environment that enhances research outcomes and drives innovation in their field.

Conclusion: Gerard M McGeehan exemplifies the spirit of innovation in the pharmaceutical industry. His groundbreaking patent work surrounding di-aryl acid derivatives positions him as a significant contributor to therapeutic advancements, ultimately benefiting patients and the medical community at large.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…